AB Science S.A.

$1.12+0.00%(+$0.00)
TickerSpark Score
48/100
Weak
20
Valuation
60
Profitability
80
Growth
52
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABSCF research report →

52-Week Range0% of range
Low $1.12
Current $1.12
High $2.70

Companywww.ab-science.com

AB Science S. A. , a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines.

CEO
Alain Moussy
IPO
2011
Employees
40
HQ
Paris, FR

Price Chart

-30.00% · this period
$1.60$1.36$1.12May 20Nov 18May 20

Valuation

Market Cap
$78.15M
P/E
-45.37
P/S
57.41
P/B
-4.11
EV/EBITDA
-18.89
Div Yield
0.00%

Profitability

Gross Margin
61.33%
Op Margin
-103.66%
Net Margin
-132.62%
ROE
6.99%
ROIC
-5.52%

Growth & Income

Revenue
$1.17M · 9.47%
Net Income
$-1,556,416 · 80.12%
EPS
$-0.03 · 83.07%
Op Income
$-1,216,543
FCF YoY
-1334.94%

Performance & Tape

52W High
$2.70
52W Low
$1.12
50D MA
$1.34
200D MA
$1.33
Beta
1.18
Avg Volume
15

Get TickerSpark's AI analysis on ABSCF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our ABSCF Coverage

We haven't published any research on ABSCF yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate ABSCF Report →

Similar Companies